PBYI - Puma Biotechnology Inc. (PBYI) Q1 2024 Earnings Call Transcript
2024-05-02 22:11:10 ET
Puma Biotechnology, Inc. (PBYI)
Q1 2024 Earnings Conference Call
May 02, 2024 4:30 PM ET
Company Participants
Mariann Ohanesian – Senior Director-Investor Relations
Alan Auerbach – Chief Executive Officer, President and Chairman of the Board
Jeff Ludwig – Chief Commercial Officer
Maximo Nougues – Chief Financial Officer
Conference Call Participants
Ed White – H.C. Wainwright
Divya Rao – TD Cowen
Presentation
Operator
Good afternoon. My name is Camilla, and I will be your conference call operator today. At this time all participants are in a listen-only mode. After the speakers’ formal remarks, there will be a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. You may begin your conference.
Mariann Ohanesian
Thank you, Camilla. Good afternoon, and welcome to Puma’s conference call to discuss our Financial Results for the First Quarter of 2024. Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; and Jeff Ludwig, Chief Commercial Officer.
After market closed today, Puma issued a news release detailing first quarter 2024 financial results. That news release, the slides that Jeff will refer to and a webcast of this call are accessible via the homepage and Investors sections of our website at pumabiotechnology.com. The webcast and presentation slides will be archived on our website and available for replay for the next 90 days....
Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript